{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T19:10:53Z","timestamp":1766603453800},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To describe the association of the rare and serious complication of liver toxicity in previously healthy Grave\u2019s disease (GD) patients after the treatment with radioactive iodine <jats:sup>131<\/jats:sup>I (RAI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We report the clinical, laboratory and pathologic findings of 2 cases of severe liver toxicity associated with the treatment with RAI in previously healthy patients with GD. Clinical examination and laboratory investigations excluded viral hepatitis, autoimmune hepatitis, granulomatous disease, primary biliary disease, extrahepatic biliary obstruction, and heart failure.<\/jats:p>\n            <jats:p>Case 1: A previously healthy 52-years old man reportedly having a typical GD but following RAI treatment, concomitantly developed severe liver toxicity that required 1\u00a0week of treatment in hospital.<\/jats:p>\n            <jats:p>Case 2: A previously healthy 34-years old woman is reported as having a typical GD but developed jaundice following RAI treatment that required several weeks of in hospital treatment in the hepato-biliary department.<\/jats:p>\n            <jats:p>In both cases, the liver dysfunction resolved after intensive treatment with hepato-protective agents. In this report the therapeutic considerations as well as the pathogenetic possibilities are reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>To the best of our knowledge, this is the first description of the association observed, which is rare but may be severe and should be considered in any case of thyrotoxicosis where a liver dysfunction develops after the treatment with radioactive iodine <jats:sup>131<\/jats:sup>I.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-6614-6-4","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T07:37:08Z","timestamp":1363419428000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Iodine-131 induced hepatotoxicity in previously healthy patients with Grave\u2019s disease"],"prefix":"10.1186","volume":"6","author":[{"given":"Navina Priya","family":"Jhummon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Tohooloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"key":"168_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/thy.1998.8.1179","volume":"8","author":"P Lind","year":"1998","unstructured":"Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I: Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 1998, 8: 1179\u20131183. 10.1089\/thy.1998.8.1179","journal-title":"Thyroid"},{"key":"168_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/thy.1997.7.163","volume":"7","author":"CT Sawin","year":"1997","unstructured":"Sawin CT, Becker DV: Radioiodine and the treatment of hypertyroidism: the early history. Thyroid 1997, 7: 163\u2013176. 10.1089\/thy.1997.7.163","journal-title":"Thyroid"},{"key":"168_CR3","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","volume":"37","author":"PM Stokkel","year":"2010","unstructured":"Stokkel PM, Junak DH, Lassmann M, Dietlein M, Luster M: EANM procedure guidelines for therapy of benign thyroid disease. Marcel Eur J Nucl Med Mol Imaging 2010, 37: 2218\u20132228. 10.1007\/s00259-010-1536-8","journal-title":"Marcel Eur J Nucl Med Mol Imaging"},{"key":"168_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2265.2007.02841.x","volume":"66","author":"AP Weetman","year":"2007","unstructured":"Weetman AP: Radioiodine treatment for benign thyroid diseases. Clin Endocrinol (Oxf) 2007, 66: 757\u2013764. 10.1111\/j.1365-2265.2007.02841.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"168_CR5","first-page":"366","volume":"133","author":"M Horejsov\u00e1","year":"1994","unstructured":"Horejsov\u00e1 M, Urban J: The effect of polyene phosphatidylcholine (Essentiale forte) in the treatment of liver steatosis and ultrasound findings\u2013preliminary study. Cas Lek Cesk 1994,133(12):366\u2013369.","journal-title":"Cas Lek Cesk"},{"key":"168_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/157340609787049316","volume":"5","author":"GT Liu","year":"2009","unstructured":"Liu GT: Bicyclol: a novel drug for treating chronic viral hepatitis B and C. Med Chem 2009, 5: 29\u201343. 10.2174\/157340609787049316","journal-title":"Med Chem"},{"issue":"10","key":"168_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2165\/00044011-200121100-00003","volume":"21","author":"W Bao-en","year":"2001","unstructured":"Bao-en W: Ademetionine 1,4-Butanedisulphonate vs Traditional Chinese medicine for the treatment of acute viral hepatitis with hepatocellular jaundice. Clin Drug Investig 2001,21(10):685\u2013694. Adis International 10.2165\/00044011-200121100-00003","journal-title":"Clin Drug Investig"},{"key":"168_CR8","author":"Y-y Yang","year":"2009","unstructured":"Yang Y-y, Zhu J-f: Clinical efficacy of Magnesium Isoglycyrrhizinate injection in treatment of chronic hepatitis with high blood level of aminotransferase. Journal of Tongji University (Medical Science) 2009,30(6):\u2009. 1008\u20130392, 06- 0114\u201303","journal-title":"Journal of Tongji University (Medical Science)"},{"issue":"11","key":"168_CR9","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","volume":"98","author":"SA Harrison","year":"2003","unstructured":"Harrison SA, Torgerson S, Hayashi P: Vitamin E and Vitamin C Treatment Improves Fibrosis in Patients With Nonalcoholic Steatohepatitis. Am J Gastroenterol 2003,98(11):2485\u20132490. http:\/\/www.nature.com\/ajg\/journal\/v98\/n11\/full\/ajg2003574a.html 10.1111\/j.1572-0241.2003.08699.x","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"168_CR10","first-page":"111","volume":"26","author":"HF Zhang","year":"2012","unstructured":"Zhang HF, Wang LM, Dong Y: A clinical study on leucogen tablets therapy efficacy during PEG-alpha interferon and alpha-interferon in chronic hepatitis B. [Article in Chinese]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2012,26(2):111\u2013113.","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"issue":"8","key":"168_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4254\/wjh.v4.i8.248","volume":"4","author":"V Senadhi","year":"2012","unstructured":"Senadhi V, Arora D: A rare cause of drug-induced hepatitis in an immunocompromised patient and the role of glutathione. World J Hepatol 2012,4(8):248\u2013251. 10.4254\/wjh.v4.i8.248","journal-title":"World J Hepatol"},{"key":"168_CR12","unstructured":"Studies on Bifendate-Loaded Nanostructured Lipid Carriers Drug Delivery System. : ; 2012. http:\/\/www.res-medical.com\/pharmacy\/101041"},{"key":"168_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/qjmed\/95.9.559","volume":"95","author":"R Malik","year":"2002","unstructured":"Malik R, Hodgson H: The relationship between the thyroid gland and the liver. QI Med 2002, 95: 559\u2013569. 10.1093\/qjmed\/95.9.559","journal-title":"QI Med"},{"key":"168_CR14","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","volume":"37","author":"M. P. M. Stokkel & D. Handkiewicz Junak & M. Lassmann:","year":"2010","unstructured":"M. P. M. Stokkel & D. Handkiewicz Junak & M. Lassmann:: EANM procedure guidelines for therapy of benignthyroid disease. Eur J Nucl Med Mol Imaging 2010, 37: 2218\u20132228. http:\/\/www.eanm.org\/publications\/guidelines\/gl_EJNMMI_therapy_of_benign_thyroid_disease.pdf 10.1007\/s00259-010-1536-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"168_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ecl.2006.09.009","volume":"35","author":"L Mebis","year":"2006","unstructured":"Mebis L, Debaveye Y, Visser TJ, Van den BG: Changes within the thyroid axis during the course of critical illness. Endocrinol Metab Clin North Am 2006, 35: 807\u2013821. 10.1016\/j.ecl.2006.09.009","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"168_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/RLU.0b013e31818f433c","volume":"34","author":"O Om\u00fcr","year":"2009","unstructured":"Om\u00fcr O, Akg\u00fcn A: Clinical implications of diffuse hepatic uptake observed in postablative and post-therapeutic I-131 scans. Clin Nucl Med 2009,34(1):11\u201314. 10.1097\/RLU.0b013e31818f433c","journal-title":"Clin Nucl Med"},{"key":"168_CR17","volume-title":"Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical DS Endocrinologists","author":"RS Bahn","year":"2011","unstructured":"Bahn RS, Burch HB, Cooper DS: Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical DS Endocrinologists. Hyperthyroidism Management Guidelines, Endocr Pract 2011.,17(3): https:\/\/www.aace.com\/files\/hyper-guidelines-2011.pdf"},{"key":"168_CR18","first-page":"16","volume-title":"Malaysian Journal of Medical Sciences","author":"M Mumtaz","year":"2009","unstructured":"Mumtaz M, Lin LS, Hui KC: Radioiodine I-131 for the therapy of Graves\u2019 disease. Malaysian Journal of Medical Sciences 2009, 16\u20131."}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-6614-6-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:20:48Z","timestamp":1630538448000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/1756-6614-6-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1186\/1756-6614-6-4","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]},"assertion":[{"value":"27 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}